Corporate Lobbyists Vote to Keep Corporate Lobbyists in the DNC
A measure to bar corporate lobbyists from serving on the DNC was rejected with several corporate lobbyists on the DNC Rules Committee voting against it.
Page 37
A measure to bar corporate lobbyists from serving on the DNC was rejected with several corporate lobbyists on the DNC Rules Committee voting against it.
Last week, the FBI arrested Ohio House Speaker Larry Householder and four associates in a bribery investigation over a law that sends $1 billion from ratepayers to bail out two nuclear power plants.
Rep. Joe Kennedy said this week that his family trusts had divested from oil and gas company stocks, though one of the funds recently bought stock in Berkshire Hathaway, a conglomerate which owns natural gas and coal companies.
Political spending in state elections by LLC's and nonprofit groups has surged in the decade since Citizens United, but some states are leading the way in strengthening disclosure laws around who’s buying and funding campaign ads.
As the economy collapsed in the pandemic, oil and gas companies that have donated over $10 million to Republican super PACs got tax breaks and lease pauses from Interior Secretary David Bernhardt, a former fossil fuel industry lobbyist.
Nearly three-quarters of contributions in state elections come from large donors and PACs, but small-dollar donations could make up that share if states move to adopt public financing for campaigns.
Billionaire Education Secretary Betsy DeVos sold up to $5 million in securities through an offshore fund that appears in the Paradise Papers.
Police groups have donated almost $15 million to state and local elected officials since 2015, with two-thirds going to Democrats, according to new data from the NoMoreCopMoney project.
With the state's public financing system not yet in place, New York candidates going up against entrenched incumbents face new fundraising challenges brought on by the coronavirus pandemic.
After months of questions from local activists, Adam Schleifer, running in the NY-17 Democratic primary, tells Sludge he supports a Senate bill that sets price restrictions on drugs developed with public funding.